The first 60 days: Low-grade appendiceal mucinous neoplasm and pseudomyxoma peritonei
Low-grade appendiceal mucinous neoplasm is a slow-growing appendiceal cancer that makes mucus, and when it bursts it spreads jelly through the abdomen as pseudomyxoma peritonei. It rarely spreads through blood or lymph, so it is treated by stripping all visible disease from the abdomen and washing the cavity with heated chemotherapy, an operation that gives most patients many years of life. Below, week by week, is what OnCo's record of Low-grade appendiceal mucinous neoplasm and pseudomyxoma peritonei says about the first two months: the order is typical, the timing is yours to ask about. Sections appear only where the record has something to say. Orientation, not medical advice.
What happens now
Staging tests establish exactly what and where the cancer is. Everything else follows from the answers.
Ask which of these were tested and what the results were; see the report reader for what each value means.
These specialties appear in the standard of care for this cancer. In most centres they meet weekly as a tumour board to agree each plan; you can ask when yours was discussed and what was decided.
- PathologistNamed in the standard of care for: Unresectable or recurrent disease.
- RadiologistNamed in the standard of care for: LAMN confined to the appendix.
- SurgeonNamed in the standard of care for: LAMN confined to the appendix, Pseudomyxoma peritonei, resectable, High-grade pseudomyxoma peritonei, Unresectable or recurrent disease.
- Medical oncologistNamed in the standard of care for: Pseudomyxoma peritonei, resectable, High-grade pseudomyxoma peritonei, Unresectable or recurrent disease.
- Clinical oncologist (radiotherapy)Named in the standard of care for: Pseudomyxoma peritonei, resectable.
A second opinion from a centre that treats many similar cases is normal, not rude; the standard of care tells you what to compare it against.
Each row is a setting from the standard of care, in the order it usually arises. Not all will apply to you; your stage and biomarkers decide which do. The guideline grade, where recorded, says how strong the evidence is.
Complete cytoreductive surgery (peritonectomy and organ resection) with hyperthermic intraperitoneal chemotherapy, mitomycin or oxaliplatin, in a specialist centre.
Repeat cytoreduction where feasible; debulking for symptoms; systemic chemotherapy only for high-grade histology; trials of mucolytics and pressurised intraperitoneal aerosol chemotherapy.
Appendicectomy with clear margin; no right hemicolectomy; surveillance imaging if mucin was found outside the appendix.
Cytoreductive surgery with HIPEC, with perioperative systemic chemotherapy (FOLFOX or CAPOX) as for appendiceal adenocarcinoma.
Generated from this cancer's standard of care, biomarkers and open problems. Take the group that matches where you are. To tick, add your own and print, open the one-page appointment sheet.
Newly diagnosed
- What is my exact diagnosis, stage, and grade, and which tests established them?Everything else follows from an accurate stage and subtype.
- Which biomarkers have been tested on my tumour (for example PSOGI grade of the peritoneal disease, Peritoneal cancer indexand completeness of cytoreduction score, GNAS mutation, KRAS; TP53 and SMAD4, CEA, CA 19-9 and CA-125, Perforation and extra-appendiceal mucin on the appendicectomy specimen), and what were the results?These results decide eligibility for targeted therapy, immunotherapy, and trials.
- Which subtype is my cancer, and does that change the recommended treatment?Recognised subtypes for this cancer include Low-grade appendiceal mucinous neoplasm confined to the appendix, LAMN with acellular mucin outside the appendix, Low-grade pseudomyxoma peritonei.
- Is germline (inherited) genetic testing recommended for me or my family?Inherited variants can change treatment and matter for relatives.
LAMN confined to the appendix
- For my situation (lamn confined to the appendix), which of the standard options do you recommend and why?Guideline options include: Appendicectomy with clear margin; no right hemicolectomy; surveillance imaging if mucin was found outside the appendix.
Pseudomyxoma peritonei, resectable
- For my situation (pseudomyxoma peritonei, resectable), which of the standard options do you recommend and why?Guideline options include: Complete cytoreductive surgery (peritonectomy and organ resection) with hyperthermic intraperitoneal chemotherapy, mitomycin or oxaliplatin, in a specialist centre.
- Am I a candidate for Mitomycin C, and what side effects should I expect?Knowing the expected toxicities helps you plan work, family, and supportive care.
High-grade pseudomyxoma peritonei
- For my situation (high-grade pseudomyxoma peritonei), which of the standard options do you recommend and why?Guideline options include: Cytoreductive surgery with HIPEC, with perioperative systemic chemotherapy (FOLFOX or CAPOX) as for appendiceal adenocarcinoma.
- Am I a candidate for FOLFOX (5-FU, leucovorin, oxaliplatin), CAPOX (capecitabine, oxaliplatin), and what side effects should I expect?Knowing the expected toxicities helps you plan work, family, and supportive care.
Unresectable or recurrent disease
- For my situation (unresectable or recurrent disease), which of the standard options do you recommend and why?Guideline options include: Repeat cytoreduction where feasible; debulking for symptoms; systemic chemotherapy only for high-grade histology; trials of mucolytics and pressurised intraperitoneal aerosol chemotherapy.
- Am I a candidate for FOLFOX (5-FU, leucovorin, oxaliplatin), and what side effects should I expect?Knowing the expected toxicities helps you plan work, family, and supportive care.
Any stage
- Are there clinical trials I could join, for example of HIPEC / PIPAC (intraperitoneal chemotherapy), HIPEC perfusion pumps and PIPAC nebulisers?Trials are how the next standard of care is set; asking early keeps options open.
- Would a second opinion at a high-volume centre change anything, and can you help arrange it?Rare or high-stakes decisions benefit from a centre that treats many similar patients.
- What supportive care (symptom control, nutrition, exercise, mental health, financial help) is available from the start?Supportive care improves quality of life and helps patients complete treatment.
- I read that “Cytoreduction with HIPEC has never been compared with cytoreduction alone in this disease”. How does that affect my plan?Open problems are where trials and second opinions matter most.
- I read that “Recurrence after complete cytoreduction is common and criteria for reoperation vary”. How does that affect my plan?Open problems are where trials and second opinions matter most.
Much of what helps in the first weeks is free if you know to ask: testing, helplines, rides and lodging, second opinions, trial travel.
- Low-grade appendiceal mucinous neoplasm and pseudomyxoma peritonei: the full pageLow-grade appendiceal mucinous neoplasm is a slow-growing appendiceal cancer that makes mucus, and when it bursts it spreads jelly through the abdomen as pseudomyxoma peritonei. It rarely spreads through blood or lymph, so it is treated by stripping all visible disease from the abdomen and washing the cavity with heated chemotherapy, an operation that gives most patients many years of life.
- One-page appointment sheetYour questions, the words you may hear, what to bring, and space for the answers. Print it.
- Treatment sequencingWhich treatment tends to follow which, line by line.
- NavigatorStandard of care for your stage, what you have tried, and trials near you.
- Debulking (cytoreductive surgery): Surgery that removes as much tumour as possible when it cannot all be removed cleanly; leaving nothing visible behind is what matters.
- HIPEC (hyperthermic intraperitoneal chemotherapy): After surgeons remove all visible tumour from the abdominal lining, the abdomen is bathed for 60-90 minutes in heated chemotherapy to kill the microscopic cells left behind.
- Colectomy: Removing the part of the colon containing the cancer along with its blood supply and lymph nodes, then joining the ends.
- Peritoneum and peritoneal metastases: The thin membrane lining the abdominal cavity and covering the bowel.
- Peritoneal metastasis: Spread across the lining of the abdomen, the most common way stomach cancer recurs and the hardest to treat.
Every term links to the glossary.